FDA Approves Nerivio for Migraine Treatment in Children Aged 8 Years and Older
Device becomes the first and only remote electrical neuromodulation wearable for migraine treatment for children 8 years and older
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.